Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis
Overview of attention for article published in Contemporary Clinical Trials, August 2016
Altmetric Attention Score: 25
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (92nd percentile)
-
High Attention Score compared to outputs of the same age and source (88th percentile)
Mentioned by
- news
- 1 news outlet
- blogs
- 1 blog
- 3 X users
- patent
- 3 patents
- guideline
- 1 clinical guideline source
Readers on
- mendeley
- 146 Mendeley